FilingReader Intelligence
Apeloa Pharmaceutical revenue falls 15% amid share buyback
August 19, 2025 at 10:10 AM UTC•By FilingReader AI
Apeloa Pharmaceutical reported revenue fell 15.31% to 5.44 billion yuan, while net profit declined 9.89% to 563 million yuan in the first half of 2025.
The company cancelled 10.88 million repurchased shares, reducing total share capital to 1.16 billion shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
SZSE:000739•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Apeloa Pharmaceutical publishes news
Free account required • Unsubscribe anytime